Purpose : To evaluate the usefulness of dynamic CT during the hepatic arterial phase with rapid IV injection of contrast material in distinguishing hepatocellular carcinorr베HCC) from intrahepatic cholangiocarcinoma (ICAC) as the cause ofbiliary obstruction.
reported, however, that if contrast-enhanced dynamic CT or dynamic MR imaging is used, contrast enhancement patterns of HCCs and ICACs are significantly different (3 -8) . If dynamic CT with rapid IV injection of contrast material is performed during the hepatic arterial phase, it is therefore possible to differentiate HCC with bile duct obstruction from ICAC.
Conventional CT or MRI findings of HCCs with bile duct involvement have recently been reported (2, 9) , but to our knowledge, description of the differential contrast-enhanced dynamic CT findings of ICAC and June-Sik Cho. et af : Differentiation of Hepatocellular Carcinoma from Intr하lepatiC Cholar빙iocarcinoma as the Cause of Biliary Obstruction HCC with intrahepatic duct obstruction have not been published. The purpose ofthis study was to determine the usefulness of dynamic CT during the hepatic arterial phase, with rapid IV injection of contrast materiaL in distinguishing HCC from ICAC as the cause of intrahepatic biliary obstruction.
Materials and Methods
Between October 1992 and February 1997, liver sonography was performed for the purpose of screening patients with clinically suspected hepatic tumors. In order to characterize these lesions, two-phase incremental or helical CT was performed; in 12 patients with pathologically proven HCCs, intrahepatic duct obstruction was diagnosed on the basis of cholangiographic, sonographic, and CT findings. As a comparison group for evaluating the differences as seen on twophase dynamic CT between ICAC and HCC, we selected 18 patients with pathologically proven ICACs; they had undergone two-phase dynamic CT scans of the liver due to hepatic tumors. Of the 18, ten who were diagnosed by cholangiography, sonography, and CT as suffering from ICAC with intrahepatic duct obstruction were included in this study. The remaining eight, who had ICACs without biliary obstruction, were excluded.
Eight of the 12 patients with HCCs were men and four were women, their mean age was 59 (range, 42 -73) years. Among the ten patients with ICACs, eight were men and two were women; their mean age was 65 (range, 46 -86) years.
Pathologic proof of HCC or ICAC was obtained by sonography-guided percutaneous core biopsy using an 18-20-gauge cutting needle. Bile duct obstruction secondary to HCCs was confirmed by a cholangiogram (percutaneous\ transhepatic cholangiography in five patients, or endoscopic retrograde cholangiography in four) and in the remaining three, bile duct obstruction was diagnosed on the basis of sonographic and CT findings.
To evaluate the enhancement patterns of lesions, a11 22 patients received a uniphasic IV injection of contrast material. A total of 150mL of non-ionic contrast medium (iodine 300mg/mL, Iopromide; Schering, Berlin, Germany) was administered with a power injector at a rate of 5 mL/second for 30 seconds. For IV injection of contrast material into the antecubital vein, an 18-20-gauge sheath needle was used . The higher bolus injection ofnonionic contrast material was well tolerated by all patients and there were no side effects.
In six patients, two-phase dynamic incremental CT scanning ofthe liver was performed with a Xpeed scanner (Toshiba Medical System, Tokyo, Japan) at 120 kVp and 150 mAs, while in 16 patients, two-phase heli cal CT scanning of the liver was performed with a HiSpeed advantage scanner (General Electric Medical System, Milwaukee, USA) at 120 kVp and 250 -280 mAs. Hepatic arterial phase images were obtained 20 -45 seconds after the initiation of IV in jection of a bolus of contrast material. For hepatic arterial phase imaging with incremental CT, the lesion was localized by precontrast CT scanning ofthe liver. When lesions were isodense on precontrast CT scans, sonographic findings were used to localized the lesion. Hepatic ar terial phase scanning with incremental CT was perfor med with a 2.7-second scanning time and a 1. 6-second interscan delay, and contiguous 5-or lO-mm collimation. Five contiguous scans with a single 25-second breath-hold were obtained at the lesion site ofthe liver as seen on precontrast CT or sonogram.
Hepatic arterial phase scanning with helical CT was performed with a l-second scan, 1: 1 pitch, 7-mm collimation, and 7-mm reconstruction. For the entire liver, 25 continuous scans with a single 25-second breath-fold were obtained. Equilibrium phase scanning was performed 2 -4 minutes after the initiation of IV injection of a bolus of contrast material. For equilib rium phase imaging, 20 contiguous scans from the diaphragmatic dome to the inferior pole of the kidney were obtained with lO-mm collimation and lO-mm interval.
HCCs were s이itary in eight patients and satellite nodules were present in four. ICACs were solitary in eight patients and satellite nodules were present in two. In cases with multiple satellite nodules, the number and size of satellite lesions were not recorded because of lack of pathologic confirmation of these lesions.
Contrast enhancement of HCCs and ICACs was classified as hypo-, iso-, or hy perattenuated, relative to enhancement of surrounding li ver parenchyma as seen on two-phase images . Each lesion was separately evaluated for homogeneity or heterogeneity of enhancement, patterns of contrast enhancement(diffuse, par-A C tial or peripheral), tumor margin(well-or ill-defined), and the presence or absence of late capsular enhancement. Capsular enhancement regarded as lesion showed thin membrane-like enhancement. Two-phase dynamic CT images in 12 patients with HCCs and ten with ICACs were retrospectively reviewed by two radiologists(C. J.S. , K.D.H.), who reached a consensus .
Two-phase CT findings were compared and correlated with histopathologic findings and clinical manifestations including the level of serum α-fetoprotein and total bilirubin. Liver cirrhosis and portal vein thrombosis were diagnosed on the basis of images obtained by sonography, CT, and clinical manifestations.
Fisher' s exact test was used to test for differences in enhancement patterns between HCCs and ICACs; a p value of < .05 was considered statistically significant.
Results
The maximum diameter of 12 HCCs ranged from 3 to 13(mean, 7. 1)cm. Nine of these HCCs were in the right hepatic lobe and three were in the left lobe; seven were B Fig. 1 . A 63-year-old woman with hepatocellular carcinoma. A. CT scan during the hepatic arterial phase shows a well-defined mass with diffuse high-enhancement (arrows) in the left hepatic lobe and moderate dilatation of the intrahepatic ducts. B. CT scan during the equilibrium phase shows a hypodense mass with capsular enhancement(arrowheads). C. CT scan during the hepatic arterial phase at the lower level ofthe liver shows a dilated common hepatic duct filled with a highly enhancing mass (arrow) representing intraluminal tumor extension into the common hepatic duct.
ill-defined and five were well-defined. The enhance ment patterns of HCCs, as seen on two-phase images, are shown in Table 1 . During the hepatic arterial phase, HCCs were hyperdense, with a moderate to marked degree of diffuse enhancement (Fig. lA) in nine (75 %) and partial enhancement in three(25 %). In four patients(33.3 %), multiple satellite nodules were also highly enhanced( Fig. 2A) . During the equilibrium phase, however, all HCCs (Figs. lB, 2B ) became hypodense and satellite nodules were poorly identified.
Incomplete or complete capsular enhancement (Fig.   lB) was seen in four cases (33.3 %). Focal dilatation of intrahepatic d ucts around the tumors, or the diffuse dilatation of both intrahepatic ducts was associated in all 12 patients with HCCs . In four HCCs, intraluminal tumor extension (Fig. 2C) into the extrahepatic duct occurred ; three of the four showed high enhancement of intraluminal tumor (Fig. lC) during the hepatic arterial phase, similar to tha t of primary tumor. The sizes of ten ICACs ranged from 5 to 10(mean, 6.9) cm in maximum diameter. Five of the ten were in the right hepatic lobe and the others were in the left lobe. Five were relatively well-defined and five were ill-defined. The enhancement patterns of ICACs on twophase images are shown in Table 1 . During the hepatic arterial phase, five ICACs (50 %) were hypodeilse (Fig.  3A) and five (50 %) were hypod-ense with peripheral enhancement (Fig. 4A) . During the equilibrium phase, however, all ICACs were hypodense with mild peripheral or central heterogeneous enhancement (Figs. 3B,  4B) . No ICACs showed capsular enhancement. Focal or diffuse dilatation of the intrahepatic ducts was seen in all ICACs. Diffuse, mild dilatation ofperipheral intrahepatic ducts was seen in three cases (30 %) and clon-A B Fig. 2 . A 58-year-old woman with hepatocellular carcinomas. A. CT scan during the hepatic arterial phase shows a large mass with diffuse high-enhancement in the left hepatic lobe and multiple small satellite nodules with high enhancement (arrowheads) are seen throughout the liver. Note direct tumor extension into the common hepatic duct(arrow). B. CT scan during the equilibrium phase shows an ill-defined hypodense mass (arrows). Multiple satellite nodules are poorly identified because lesions became slightly hypodense or isodense compared with surrounding liver parenchymal enhancement.
c. Endoscopic retrograde cholangiogram shows a focal eccentric narrowing (arrow) ofthe common hepatic duct by tumor invasion.
" orchiasis was confirmed in the stool examination (Fig  4) . During the equilibrium phase, it was difficult to differentiate HCCs with intrahepatic duct dilatation from ICACs; during the hepatic arterial phase, however, enhancement patterns ofHCCs with intrahepatic duct obstruction were significantly different (p (. 0001) from those of ICACs. Additional findings were liver cirrhosis in ten patients with HCCs and in one with ICAC. Portal vein thrombosis was found in six patients with HCCs and in one with ICAC.
Discussion
Obstructive jaundice has been regarded as an un-A Fig. 3 . A 57-year-old man with intrahepatic cholangiocarcinoma.
common complication of HCC, with an incidence of 2-8 % in patients with HCCs(l , 2, 10 -13). HCCinduced biliary obstruction can be caused by direct tumor invasion of intrahepatic ducts, pedunculated tumor extension into the extrahepatic bile ducts, blood clots or necrotic frag-ments from the tumor, and metastatic lymph node compression of the major ducts in the porta hepatis(II -13). The prognosis of patients with o bstructive jaundice due to HCC seems to be poor, since most tumors with major bile duct invasion are large and infiltrative. In order to effectively plan management strategies, the identification of specific causes of obstructive jaundice is important(2) On CT scans, intrahepatic duct dilatation secondary B A. CT scan during the hepátic arterial phase shows a hypodense mass (arrow) in the medial segment ofthe left hepatic lobe B. CT scan during the equilibrium phase shows a well-defined hypodense mass (arrow) with mild heterogeneous enhancement and moderate dilatation of both intrahepatic ducts.
A B Fig. 4 . A 56-yea r-이 d man with intrahepatic cholangiocarcinoma and clonorchiasis. A. CT scan dur e mass with peripheral enhancement (arro 에l eads) in the left hepatic lobe and marked dilatation ofthe left intrahepatic d ucts du e to hilar extension oftumor B. CT scan d uring the eq uilibrium phase shows an ill-defined hypodense mass with mild peripheral enhancement(arrowheads). Note mild , diffuse dilatation ofthe right int rahepatic du cts and clonorchiasis was confirmed in t he stool examination.
to HCC is suggested when intrahepatic duct dilatation is associated with marked elevation of serum α fetoprotein level and a well-delineated, encapsulated intrahepatic mass(L 2). Since, however, the enhancement patterns of both tumors are similar and intrahepatic duct dilatation is a common CT feature ofICAC, infiltrative HCC with bile duct invasion may be difficult to differentiate from ICAC on conventional contrast-enhanced CT scans. HCCs are hypervascular tumors which are supplied by hepatic arteries (3 -5) . They become maximally hyperdense during the hepatic arterial phase of dynamic CT and rapidly less dense during the portal venous phase, and then gradually become hypodense during the delayed phase (3 -6) . Dynamic CT during the hepatic arterial phase, with rapid bolus injection of contrast material and early initiation of scanning, has therefore been used for the detection and characterization of HCCs(5 , 6). To characterize hepatic tumors, we performed two-phase dynamic incremental or helical CT during the hepatic arterial and equilibrium phases, with rapid IV injection of contrast material. During the heaptic arterial phase, nine ofthe 12 HCCs (75 %) showed diffuse high-enhancement before adequate enhancement of surrounding liver parenchyma, and three (25 %) were partially enhanced. In addition, multiple, enhanced, small satellite nodules were readily detectable in four cases. During the equilibrium phase, however, all HCCs showed hypoattenuation relative to liver parenchyma, and because the lesions became isodense or slightly hypodense, multiple satellite nodules were poorly depicted. The enhancement patterns of HCCs with biliary obstruction, as seen on two-phase dynamic CT scans, were similar to those of HCCs without biliary obstruction.
ICACs contain abundant stroma and fibrous tissue; on contrast-enhanced CT scans, this tumor therefore appears as an irregular mass with low attenuation, mild contrast enhancement at the periphery during the early phase, and delayed or prolonged, homogeneous enhancement due to extensive interstitial space during the delayed phase (3, 6, 14 -16) . This enhancement of ICACs during the delayed phase, which is obtained 10 -20 minutes after contrast administration, is d ue to slow wash-in and wash-out of contrast material in fibrous tissue (3, 16) . Dynamic studies of ICAC using CT or MR have reported that this tumor show five cases (50%) . During this phase, enhancement patterns of HCCs were, therefore, significantly different from those ofICACs. During the equilibrium phase, all ICACs were hypodense with mild peripheral or central heterogeneous enhancement, and no capsular enhancement was seen. Because delayed-phase images were not obtained for more than ten minutes, we did not observe prolonged or delayed enhancement, a characteristic finding ofICAC. During the equilibrium phase, eight HCCs(66.7 %), which showed ill-defined hypod-ense infiltrating masses without capsular enhancement, were therefore difficult to differentiate from ICACs. However, four HCCs (33.3 %) showed complete or incomplete capsular enhancement, and this helped distinguish HCCs from ICACs.
Although we have encountered a small number of HCCs with biliary obstruction, the frequency of capsular enhancement was similar to that of HCCs without such obstruction. Soyer et al. (2) , however, reported that encapsulation was absent in all ten HCCs with intrahepatic duct dilatation and suggested that a lack of encapsulation in patients with HCCs might favor bile duct involvement. This difference between their results and ours might be explained by the fact that the frequency of HCC encapsulation among Asian populations is significantly higher than among non-Asians (17, 18) .
On conventional contrast-enhanced CT, intraluminal filling defects of the bile duct due to blood clots and/or necrotic tumor tissue are difficult to differentiate from pedunculated HCC( lO). Intrabiliary mass enhancement, however, as seen on contrast-enhanced CT scans, indicates extension of HCC rather than a blood clot (9) . In our series, intraluminal tumor extension into the bile duct, as confirmed by cholangiography, was seen in four patient~ with HCCs. In three ofthese cases, the tumor was highly enhanced during the hepatic arterial phase, resembling an enhanced primary tumor. We believe that for the diagnosis of intrabiliary extension ofHCC, such a finding is useful.
Our study has certain limitations; two-phase dynamic CT findings were evaluated in which intrahepatic duct dilatation was secondary to HCCs or ICACs -a relatively small number of cases. In our series, all 12 HCCs showed a mild to marked degree of diffuse or partial hyperattenuation during the hepatic arterial phase. Other studies, however, have reported that during t J Korean Radiol S∞ 1998: 38 : 659 -666 and others is due to our restricted number of cases.
Another limitation was that we obtained equilibrium phase instead of the delayed phase images; the latter are accepted as being ideal for the characterization of cholangiocarcinoma.
In our study, capsular enhancement ofHCCs during the equilibrium phase was helpful in differentiating these from ICACs, but it was difficult to differentiate unencapsulated infiltrative HCCs from ICACs. During the hepatic arterial phase, however, most HCCs were highly enhanced and most ICACs were poorly enhanced except in cases with peripheral enhancement. Contrast enhancement patterns of HCCs during the hepatic arterial phase were significantly different from those o fICACs. In addition, hepatic arterial-phase images helped detect small satellite nodules and intrabiliary tumor extension of HCCs. In conclusion, our results suggest that dynamic CT during the hepatic arterial phase, with rapid IV injection of contrast material, is useful for the differentiation of HCC from ICAC as the cause ofbiliary obstruction.
